International Reinsurance Brokers Solutions LLC, also known as InteRBroS, is a private independent reinsurance broker established in March 2008.

 

It operates under full licensure issued by the Florida Department of Financial Services and is incorporated in accordance with the laws of the State of Florida, USA.

​

Situated strategically within the Brickell Financial District in Miami, InteRBroS operates as a Premier Reinsurance Broker Boutique firm, focusing primarily on providing first-class service to its clients and current book of business in Latin America.

 

The company also focuses on cultivating new reinsurance opportunities across this region, including the Spanish-speaking Caribbean.

​

With a rich history spanning over 40 years, the InteRBroS team has forged robust business relationships with clients and reinsurers. These enduring partnerships have enabled InteRBroS to establish strategic alliances with key local clients, producers and providers further enhancing its market presence.

​

The direct rapport that InteRBroS has cultivated with leading reinsurers throughout the Americas, alongside its extensive global network, continues to expand. Leveraging the support of correspondent Lloyds reinsurance brokers and specialty brokers globally, InteRBroS maximizes marketing strengths and capabilities, ensuring optimal outcomes within respective local markets.

​

Specializing in the design, development, marketing, and placement of reinsurance products and solutions, InteRBroS offers comprehensive Consulting Services in Risk Management.

​

Its involvement spans across all classes of Insurance and Reinsurance Business, encompassing both facultative and treaty-based approaches.

​

InteRBroS excels particularly in large property/power energy, casualty, and marine/STP facultative realms, along with health, group life, personal accidents, and related bank-assurance/affinity products. Employing diverse distribution channels, InteRBroS accesses large groups and specific population segments with precision and efficacy.